Model
Edge
Five Prime Therapeutics, Inc.
0001518724
Filing Type
4
Filing Date
6/11/2019
Updated
6/12/19, 12:15 PM
Filing
4
Earnings Release
Exhibits
4
Statement of Changes in Beneficial Ownership